Klaus Schott

1.7k total citations
46 papers, 1.4k citations indexed

About

Klaus Schott is a scholar working on Physiology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Klaus Schott has authored 46 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Physiology, 11 papers in Cellular and Molecular Neuroscience and 10 papers in Molecular Biology. Recurrent topics in Klaus Schott's work include Alzheimer's disease research and treatments (8 papers), Tryptophan and brain disorders (6 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Klaus Schott is often cited by papers focused on Alzheimer's disease research and treatments (8 papers), Tryptophan and brain disorders (6 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Klaus Schott collaborates with scholars based in Germany, United States and Switzerland. Klaus Schott's co-authors include Gerhard Buchkremer, Elke Stransky, Christoph Laske, E. Richartz, M. Bartels, Thomas Leyhe, Gerhard W. Eschweiler, Andreas Wittorf, Anil Batra and Walter Maetzler and has published in prestigious journals such as PLoS ONE, Journal of Neurochemistry and European Journal of Neuroscience.

In The Last Decade

Klaus Schott

45 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Klaus Schott Germany 17 526 425 353 261 242 46 1.4k
Helton José Reis Brazil 27 311 0.6× 470 1.1× 322 0.9× 525 2.0× 343 1.4× 75 1.9k
Paige W. Sholar United States 10 462 0.9× 378 0.9× 707 2.0× 230 0.9× 282 1.2× 11 1.6k
Valeria Studer Italy 24 165 0.3× 390 0.9× 667 1.9× 387 1.5× 251 1.0× 40 1.9k
Marzia Pesaresi Italy 27 475 0.9× 384 0.9× 162 0.5× 368 1.4× 62 0.3× 38 1.7k
Romain‐Daniel Gosselin Switzerland 19 718 1.4× 570 1.3× 399 1.1× 368 1.4× 168 0.7× 28 1.6k
Joseph C. Biedenkapp United States 20 932 1.8× 920 2.2× 832 2.4× 348 1.3× 273 1.1× 27 2.5k
Anna Parachikova United States 14 652 1.2× 210 0.5× 401 1.1× 306 1.2× 192 0.8× 14 1.2k
Sama F. Sleiman United States 17 634 1.2× 321 0.8× 168 0.5× 785 3.0× 182 0.8× 27 1.8k
Yi He China 25 415 0.8× 211 0.5× 422 1.2× 539 2.1× 383 1.6× 70 2.0k
Chun‐Hsien Chu Taiwan 24 238 0.5× 413 1.0× 468 1.3× 582 2.2× 162 0.7× 60 1.8k

Countries citing papers authored by Klaus Schott

Since Specialization
Citations

This map shows the geographic impact of Klaus Schott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Klaus Schott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Klaus Schott more than expected).

Fields of papers citing papers by Klaus Schott

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Klaus Schott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Klaus Schott. The network helps show where Klaus Schott may publish in the future.

Co-authorship network of co-authors of Klaus Schott

This figure shows the co-authorship network connecting the top 25 collaborators of Klaus Schott. A scholar is included among the top collaborators of Klaus Schott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Klaus Schott. Klaus Schott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Koehler, Niklas, Elke Stransky, Mona Shing, et al.. (2013). Altered Serum IgG Levels to α-Synuclein in Dementia with Lewy Bodies and Alzheimer’s Disease. PLoS ONE. 8(5). e64649–e64649. 33 indexed citations
2.
Laske, Christoph, Reinhild Klein, Elke Stransky, et al.. (2007). Autoantibody reactivity in serum of patients with major depression, schizophrenia and healthy controls. Psychiatry Research. 158(1). 83–86. 62 indexed citations
3.
Maetzler, Walter, Daniela Berg, Arthur Melms, et al.. (2007). Osteopontin is elevated in Parkinson’s disease and its absence leads to reduced neurodegeneration in the MPTP model. Neurobiology of Disease. 25(3). 473–482. 100 indexed citations
4.
Mau‐Holzmann, Ulrike A., et al.. (2006). Prädiktive Diagnostik bei Chorea Huntington: Psychotherapeutische Aspekte der Beratung von Risikopersonen. Psychiatrische Praxis. 33(5). 211–217. 3 indexed citations
5.
Batra, Anil, Elke Stransky, Christoph Laske, et al.. (2006). Altered lymphocyte distribution in Alzheimer’s disease. Journal of Psychiatric Research. 41(1-2). 174–178. 134 indexed citations
6.
Laske, Christoph, Elke Stransky, Thomas Leyhe, et al.. (2006). BDNF serum and CSF concentrations in Alzheimer’s disease, normal pressure hydrocephalus and healthy controls. Journal of Psychiatric Research. 41(5). 387–394. 233 indexed citations
7.
Richartz, E., Anil Batra, Perikles Simon, et al.. (2005). Diminished Production of Proinflammatory Cytokines in Patients with Alzheimer’s Disease. Dementia and Geriatric Cognitive Disorders. 19(4). 184–188. 25 indexed citations
8.
Laske, Christoph, Elke Stransky, Thomas Leyhe, et al.. (2005). Stage-dependent BDNF serum concentrations in Alzheimer’s disease. Journal of Neural Transmission. 113(9). 1217–1224. 271 indexed citations
9.
Schott, Klaus, et al.. (2004). Simulations with LS-DYNA for Registration Approval of a Coach according to ECE R66 Regulation. elib (German Aerospace Center). 3 indexed citations
10.
Simon, Perikles, Klaus Schott, Robert W. Williams, & Frank Schaeffel. (2004). Posttranscriptional regulation of the immediate‐early gene EGR1 by light in the mouse retina. European Journal of Neuroscience. 20(12). 3371–3377. 16 indexed citations
11.
Schott, Klaus, et al.. (2002). T‐wave response: a sensitive test for latent alcoholic polyneuropathy. Addiction Biology. 7(3). 315–319. 1 indexed citations
12.
Schott, Klaus, Anil Batra, E. Richartz, et al.. (1998). Antibrain antibodies in mental disorder: no evidence for antibodies against synaptic membranes. Journal of Neural Transmission. 105(4). 517–517. 3 indexed citations
13.
Schott, Klaus, H. Wormstall, Maren Dietrich, Reinhild Klein, & Anil Batra. (1996). Autoantibody reactivity in serum of patients with alzheimer's disease and other age-related dementias. Psychiatry Research. 59(3). 251–254. 19 indexed citations
14.
Schott, Klaus, et al.. (1996). Antinuclear antibodies in schizophrenia and major depressive disorder — a lasting puzzle. European Psychiatry. 11(5). 263–267. 6 indexed citations
15.
Schabet, Martin, John N. Whitaker, Klaus Schott, et al.. (1991). The use of protease inhibitors in experimental allergic neuritis. Journal of Neuroimmunology. 31(3). 265–272. 18 indexed citations
16.
Schott, Klaus, et al.. (1991). T-wave response in cervical root lesions. Acta Neurologica Scandinavica. 84(4). 273–276. 12 indexed citations
17.
Schott, Klaus, et al.. (1990). Proteolysis of peripheral nerve myelin in acute experimental allergic neuritis. Neurochemical Research. 15(9). 855–859. 1 indexed citations
18.
Stevens, Andreas, Martin Schabet, H. Wiethölter, & Klaus Schott. (1990). Prednisolone therapy of experimental allergic neuritis in Lewis rats does not induce relapsing or chronic disease. Journal of Neuroimmunology. 28(2). 141–151. 2 indexed citations
19.
Stevens, Andreas, et al.. (1989). Role of endoneural cells in experimental allergic neuritis and characterisation of a resident phagocytic cell. Acta Neuropathologica. 77(4). 412–419. 20 indexed citations
20.
Schott, Klaus, et al.. (1988). Free amino acid pattern of cerebrospinal fluid in amyotrophic lateral sclerosis. Acta Neurologica Scandinavica. 77(1). 50–53. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Helton José Reis Breakdown of academic impact, for papers by Paige W. Sholar Breakdown of academic impact, for papers by Valeria Studer Breakdown of academic impact, for papers by Marzia Pesaresi Breakdown of academic impact, for papers by Romain‐Daniel Gosselin Breakdown of academic impact, for papers by Joseph C. Biedenkapp Breakdown of academic impact, for papers by Anna Parachikova Breakdown of academic impact, for papers by Sama F. Sleiman Breakdown of academic impact, for papers by Yi He Breakdown of academic impact, for papers by Chun‐Hsien Chu
Rankless by CCL
2026